Torrent Pharmaceuticals Ltd. - Research Center
500420 TORNTPHARM Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
2,143.00 |
2,123.00 |
2,146.00 |
2,121.00 |
1,920.00 |
Operating profit |
716.00 |
701.00 |
736.00 |
737.00 |
578.00 |
Interest |
67.00 |
69.00 |
77.00 |
90.00 |
94.00 |
Gross profit |
725.00 |
621.00 |
674.00 |
658.00 |
510.00 |
EPS (Rs) |
12.11 |
8.78 |
9.66 |
9.54 |
6.47 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
76.00 |
-11.00 |
15.00 |
11.00 |
26.00 |
Stock adjustment |
-39.00 |
56.00 |
-46.00 |
-40.00 |
-1.00 |
Raw material |
409.00 |
376.00 |
433.00 |
434.00 |
387.00 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
353.00 |
363.00 |
366.00 |
369.00 |
327.00 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
704.00 |
627.00 |
657.00 |
621.00 |
629.00 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
195.00 |
191.00 |
192.00 |
183.00 |
182.00 |
Taxation |
120.00 |
133.00 |
155.00 |
152.00 |
109.00 |
Net profit / loss |
410.00 |
297.00 |
327.00 |
323.00 |
219.00 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
169.23 |
169.23 |
169.23 |
169.23 |
169.23 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
33.41 |
33.02 |
34.30 |
34.75 |
30.10 |
GPM (%) |
32.67 |
29.40 |
31.19 |
30.86 |
26.21 |
NPM (%) |
18.48 |
14.06 |
15.13 |
15.15 |
11.25 |